https://bitox.bsmo.be/portfolio-item/portfolio/2025-01-18T21:29:48+01:00https://bitox.bsmo.be/portfolio-item/pfjointtoxicity/2025-05-18T17:03:49+02:00https://bitox.bsmo.be/portfolio-item/arthralgia/2025-05-10T22:49:43+02:00https://bitox.bsmo.be/portfolio-item/arthralgia-grade-1/2025-05-10T22:49:37+02:00https://bitox.bsmo.be/portfolio-item/pf-1-2-inflammatory-arthralgia-2/2025-04-26T17:21:13+02:00https://bitox.bsmo.be/portfolio-item/pf-1-3-arthritis/2025-04-26T17:27:17+02:00https://bitox.bsmo.be/portfolio-item/pf-colitis/2025-05-18T17:03:40+02:00https://bitox.bsmo.be/portfolio-item/pf-1-1-1-colitis-grade-2/2025-05-11T18:00:37+02:00https://bitox.bsmo.be/portfolio-item/pf-1-2-1-colitis-grade-3-4/2025-05-11T18:00:28+02:00https://bitox.bsmo.be/portfolio-item/cc-cs234mry-pf-1-2-1-colitis-medium-risk-yes/2025-05-11T17:08:56+02:00https://bitox.bsmo.be/portfolio-item/pf-1-1-1-colitis-grade-2-low-risk/2025-05-11T11:24:10+02:00https://bitox.bsmo.be/portfolio-item/ca-pf-1-1-1-1-colitis-grade-2-low-risk-yes/2025-05-11T16:36:55+02:00https://bitox.bsmo.be/portfolio-item/cb-pf-1-1-1-2-colitis-grade-2-low-risk-no/2025-05-11T16:37:42+02:00https://bitox.bsmo.be/portfolio-item/cdn-cs234mry-pf-1-2-1-colitis-grade-2-medium-risk-no/2025-05-11T17:25:27+02:00https://bitox.bsmo.be/portfolio-item/pf-1-1-2-colitis-grade-2-medium-risk-stop-yes-no/2025-05-11T16:44:45+02:00https://bitox.bsmo.be/portfolio-item/cdnn-cs234mrnn-pf-1-2-1-colitis-grade-2-medium-risk-no-no/2025-05-11T17:33:55+02:00https://bitox.bsmo.be/portfolio-item/cdnnn-cs234mrnn-pf-1-2-1-colitis-grade-2-medium-risk-no-no-no/2025-05-11T17:30:15+02:00https://bitox.bsmo.be/portfolio-item/pf-skin-toxicity/2025-05-18T17:00:35+02:00https://bitox.bsmo.be/portfolio-item/pf-skin-toxicity-grade-1/2025-05-18T17:00:40+02:00https://bitox.bsmo.be/portfolio-item/pf-skin-toxicity-grade-2-4/2025-05-18T17:00:46+02:00https://bitox.bsmo.be/portfolio-item/pf-hepatitis/2025-05-18T17:00:54+02:00https://bitox.bsmo.be/portfolio-item/pf-hepatitis-grade-2/2025-05-18T17:00:59+02:00https://bitox.bsmo.be/portfolio-item/pf-hepatitis-grade-1/2025-08-03T11:22:23+02:00https://bitox.bsmo.be/portfolio-item/pf-hepatitis-grade-3/2025-05-11T19:11:10+02:00https://bitox.bsmo.be/portfolio-item/pf-hepatitis-grade-4/2025-05-11T19:07:35+02:00https://bitox.bsmo.be/portfolio-item/pf-nephritis/2025-05-18T17:01:20+02:00https://bitox.bsmo.be/portfolio-item/pf-muscle-pathology/2025-05-18T17:11:18+02:00https://bitox.bsmo.be/portfolio-item/pf-combination-therapy-ici-tki/2025-10-30T15:35:19+01:00https://bitox.bsmo.be/portfolio-item/pfae-possibly-related-to-both-ici-and-tki/2025-10-30T15:02:53+01:00https://bitox.bsmo.be/portfolio-item/pf-ae-considered-related-to-tki/2025-10-30T15:04:52+01:00https://bitox.bsmo.be/portfolio-item/pf-endocrine/2025-05-18T17:01:43+02:00https://bitox.bsmo.be/portfolio-item/neurologic/2025-05-24T16:24:38+02:00https://bitox.bsmo.be/portfolio-item/pf-endocrine-hypothyroidism/2025-05-18T17:01:52+02:00https://bitox.bsmo.be/portfolio-item/pf-endocrine-hyperthyroidism/2025-05-18T17:02:00+02:00https://bitox.bsmo.be/portfolio-item/pf-endocrine-diabetes-mellitus/2025-05-18T17:02:04+02:00https://bitox.bsmo.be/portfolio-item/pf-endocrine-adrenalitis/2025-05-18T17:02:09+02:00https://bitox.bsmo.be/portfolio-item/pf-endocrine-hypophysitis/2025-05-18T17:02:13+02:00https://bitox.bsmo.be/portfolio-item/pneumonitis/2025-05-18T17:38:04+02:00https://bitox.bsmo.be/portfolio-item/uncomplicated-peripheral-neuropathy/2025-05-24T16:01:40+02:00https://bitox.bsmo.be/portfolio-item/peripheral-neuropathy-guillain-barre-syndrome/2025-05-24T16:06:16+02:00https://bitox.bsmo.be/portfolio-item/transversal-myelitis/2025-05-24T16:12:49+02:00https://bitox.bsmo.be/portfolio-item/central-neurological-toxicity-encephalitis/2025-05-24T16:15:23+02:00https://bitox.bsmo.be/portfolio-item/central-neurological-toxicity-aseptic-meningitis/2025-05-24T16:24:13+02:00